Birdwatch Note Rating
2024-11-28 23:21:33 UTC - NOT_HELPFUL
Rated by Participant: 7BDA2E8DE14E2F059E3136CD600F510F44034A286C08B5FE5DD05C0569810E25
Participant Details
Original Note:
The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a
All Note Details